Injectable Drug Delivery Market Growth, Size, Share, Trends, and Forecast 2032

Injectable Drug Delivery Industry Prospective:

The global injectable drug delivery market size was worth around USD 697.59 million in 2023 and is predicted to grow to around USD 1493.96 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.83% between 2024 and 2032.

Request Free Sample

In order to give the users of this report a comprehensive view of the injectable drug delivery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Injectable Drug Delivery Market: Growth Drivers

Injecting of medicines or drugs directly into patients’ blood via a delivery device is called injectable drug delivery. Some pharmaceutical agents, predominant peptides, proteins, etc. can be administered via injectable routes. The parenteral administration route is one of the most common and efficient drug delivery types. Injectable drug delivery ensures a quick passage of a drug into the body by avoiding first pass metabolism. This drug delivery system also helps in administering drugs in comatose patients. For various medical conditions, such as cystic fibrosis, hormonal imbalance, autoimmune diseases, Wilson’s disease, hepatitis C, ribose-5-phosphate isomerase, and hemophilia, the injectable drug delivery system is preferred mostly.

The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc., and technological innovations related to advanced device development in injectable drug delivery systems.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

Injectable Drug Delivery Market: Segmentation

The study provides a decisive view of the injectable drug delivery market based on type, application, end-user, and region.

By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others.

By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others.

By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others.

Injectable Drug Delivery Market: Report Scope

Injectable Drug Delivery Market: Regional Analysis

By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. North America held the largest share of the global market in 2017 and is anticipated to remain dominant over the forecast time period as well. In terms of growth rate, the Asia Pacific region is expected to register the highest CAGR over the estimated time period. India and China held the largest shares of the Asia Pacific injectable drug delivery market in 2018.

Injectable Drug Delivery Market: Competitive Analysis

The global injectable drug delivery market is dominated by players like:

• Baxter International
• Nova Nordisk A/S
• Becton Dickinson
• Sanofi
• Pfizer
• InjexPharma GmbH
• Terumo Corporation
• Unilife Corporation
• Gerresheimer AG
• Vetter Pharma-Fertigung GmbH & Co. KG
• Schott AG
• Eli Lily & Company

This report segments the global injectable drug delivery market into:

Global Injectable Drug Delivery Market: Type Analysis

• Formulation
  • Conventional Drug Delivery
    • Suspensions
    • Solutions
    • Lyophilized Formulations
    • Emulsions
  • Novel Drug Delivery
    • Long Acting Injection Formulation
    • Microparticles
    • Colloidal Dispersions
  • Others
• Devices
  • Self-Injection Devices
    • Needle-Free Injectors (NFI)
    • Wearable Injectors
    • Pen Injectors
    • Auto-Injectors
    • Others 
  • Conventional Injection Devices
    • Prefilled Syringes
    • Fillable Syringes
    • Others

Global Injectable Drug Delivery Market: Application Analysis

• Autoimmune Diseases
• Oncology Disorders
• Hormonal Disorders
• Orphan Diseases
• Others

Global Injectable Drug Delivery Market: End-User Analysis

• Home Care
• Hospital
• Ambulatory Care
• Physician Offices or Clinics
• Others

Global Injectable Drug Delivery Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa